BENEVICH ERIC bought NBIX
March 14, 2024 · Form 4 insider transaction
BENEVICH ERIC bought 5,479 shares of Neurocrine Biosciences, Inc. at $79.02 per share, a transaction worth $433.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
5,479
Price
$79.02
Total value
$433.0K
InsiderBENEVICH ERIC
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 14, 2024
Filing dateMarch 15, 2024
Shares owned after46,257
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes an aggregate of 162 shares purchased on February 29, 2024 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan.